|
- 2019
Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective StudyKeywords: atrial fibrillation, valvular heart disease, vitamin K antagonists, non–vitamin K oral anticoagulants Abstract: Background ?Valvular heart disease (VHD) and atrial fibrillation (AF) often coexist
|